Birgit Stattin Norinder
Direktor/Vorstandsmitglied bei ADDLIFE AB
Vermögen: 118 118 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mårten Rooth | M | 47 | 17 Jahre | |
| Göran Albert Ando | M | 75 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 12 Jahre |
| Eva Nilsagård | F | 60 | 9 Jahre | |
| Bengt Arne Gustavsson | M | 61 | 7 Jahre | |
| Robert Maiorana | M | 64 | 4 Jahre | |
| Peter Mikael Simonsbacka | M | 64 | 7 Jahre | |
| Stefan Hedelius | M | 55 | 9 Jahre | |
| Lauren Silvernail | F | 65 | 7 Jahre | |
| Anders Johansson | M | 48 | 17 Jahre | |
| Magnus Westgren | M | 73 | 9 Jahre | |
| Richard Davis | M | 51 | 2 Jahre | |
| Les Kaplan | M | 73 | 10 Jahre | |
| Lars Håkan Påvel Roos | M | 69 | 9 Jahre | |
| Sten Gunnar Otto Skolling | M | 62 | 9 Jahre | |
| Jakob Dynnes Hansen | M | 69 | 1 Jahre | |
| Luzi Andreas von Bidder | M | 71 | 10 Jahre | |
| Adrienne Graves | M | 69 | 10 Jahre | |
| Johan Olov Sjö | M | 57 | 9 Jahre | |
| Eva Maria Cecilia S. Elmstedt | F | 64 | 3 Jahre | |
| Mattias Bengtsson | M | 55 | - | |
| Marie Gårdmark | M | 59 | - | |
| Nichlas Essner | M | - | 2 Jahre | |
| Johanna Röstin | F | 57 | 3 Jahre | |
| Håkan Olsson Reising | M | 63 | 7 Jahre | |
| Per Jonas Eriksson | M | 50 | 9 Jahre | |
| Morten Willemoes Dyrner | M | - | - | |
| Fredrik Dalborg | M | 52 | 2 Jahre | |
| Roger Tell | M | 59 | 2 Jahre | |
| Jamilah Wass | F | - | 7 Jahre | |
| Björn Svanström | M | 53 | 5 Jahre | |
| Lina Åström | F | - | 8 Jahre | |
| Sven Undeland | M | 63 | 8 Jahre | |
| Pål Ryfors | M | 41 | 2 Jahre | |
| Christina Rubenhag | F | - | 2 Jahre | |
| Christian Karlsson | M | - | - | |
| David Westberg | M | 64 | 9 Jahre | |
| Joel Hellrup | M | 41 | 8 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Bretherton | M | 68 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Kristina Willgård | F | 59 | 7 Jahre | |
| Karl Härfstrand | M | 66 | 3 Jahre | |
| Carina Eklöw | F | - | 1 Jahre | |
| Gunilla Öhman | F | 65 | 1 Jahre | |
| Per Fredrik Börjesson | M | 46 | - | |
| Artur Bernardino Aira | M | 57 | 3 Jahre | |
| Martin Almgren | M | 48 | - | |
| Philippe Masquida | M | 62 | 4 Jahre | |
| Kevin Kissane | M | 69 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Michael Lewis | M | 66 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 3 Jahre |
| Ursula Ney | M | 72 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 6 Jahre |
| Andrea Buscaglia | M | 60 | 1 Jahre | |
| Gunnar Andreas Göthberg | M | 57 | - | |
| Glyn Owain Edwards | M | 68 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 13 Jahre |
| Daniel W. Elger | M | 54 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 6 Jahre |
| Dale J. Boden | M | 67 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 7 Jahre |
| Helga Zharov | F | 57 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 8 Jahre |
| Vaughn M. Kailian | M | 79 | 13 Jahre | |
| Gerald W. St. Peter | M | 57 | - | |
| Jean-Luc Bélingard | M | 74 | 9 Jahre | |
| Heidi Ramstad | M | 55 | - | |
| Peter Selin | M | - | - | |
| Anders Holmström | M | - | - | |
| Sophia Dernulf | F | - | - | |
| Michael af Winklerfelt | M | 52 | 1 Jahre | |
| Linda B. Buck | M | 77 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 Jahre |
| Maria Nilsson Hagberg | F | - | 2 Jahre | |
| Peter Goodfellow | M | 72 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 Jahre |
| Michael A. Boss | M | 69 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Terry McGuire | M | 68 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 12 Jahre |
| Tomas Navratil | M | 47 | - | |
| Michael Bergamini | M | - | 5 Jahre | |
| Stephane Nicolas | M | 55 | - | |
| Pascal Pfister | M | 66 | 5 Jahre | |
| Francois Ducret | M | - | - | |
| Ann V. Hacker | F | - |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Eric Todd | M | - |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Gary Acton | M | 65 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Mark Hudson | M | - |
Prolifix Ltd.
| - |
| Barry James Price | M | 80 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 14 Jahre |
| Vicente J. Anido | M | 71 | 1 Jahre | |
| Evelyne Nguyen | F | 56 | - | |
| Jørgen Buus Lassen | M | 90 | 24 Jahre | |
| Bengt Ingemar Samuelsson | M | 90 | 15 Jahre | |
| Reinhard Koenig | M | 64 | - | |
| Jakob Sigurðsson | M | 60 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 Jahre |
| Eric Castaldi | M | 59 | 16 Jahre | |
| Daniel Tesfa | M | 55 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Schweden | 50 | 58,14% |
| Frankreich | 19 | 22,09% |
| Vereinigtes Königreich | 13 | 15,12% |
| Island | 6 | 6,98% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Birgit Stattin Norinder
- Persönliches Netzwerk
